1-2 of 2
Houston Holmes, MD FACP
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1 Results of ZUMA-3: KTE-C19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL)

Bijal D. Shah, MD, Wendy Stock, MD, William G Wierda, MD PhD, Olalekan Oluwole, MBBS, MPH, Houston Holmes, MD FACP, Gary J. Schiller, MD FACP, Max S. Topp, MD, Marie José Kersten, MD PhD, Roch Houot, MD PhD, Nicolas Boissel, MD PhD, Michelle Mojadidi, MSc, Allen Xue, PhD, Armen Mardiros, PhD, Yizhou Jiang, PhD, Tong Shen, PhD, Jeff S. Aycock, Shanna Stout, Jeffrey S. Wiezorek, MD MS, Rajul Jain, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 888.
https://doi.org/10.1182/blood.V130.Suppl_1.888.888
Published: 2017
Journal Articles

Contempo: Preliminary Results in First-Line Treatment of Follicular Lymphoma with the Oral Dual PI3K-δ,γ Inhibitor, Duvelisib, in Combination with Rituximab or Obinutuzumab

Carla Casulo, MD, Juan-Manuel Sancho, Koen Van Eygen, MD, Sven de Vos, MD PhD, Santiago Mercadal, MD, Roderick J. Johnson, MD, Kamal Bouabdallah, MD, Houston Holmes, MD FACP, Jan Lemmens, MD, Emmanuel Gyan, MD, Michele Merli, MD, Ranjana H Advani, MD, Lori Steelman, MA, Joseph Pearlberg, MD PhD, Andre Goy, MD
Journal: Blood
Blood (2016) 128 (22): 2979.
https://doi.org/10.1182/blood.V128.22.2979.2979
Published: 2016